Related Experiment Videos
Megakaryocytic leukemia; identification utilizing anti-factor VIII immunoperoxidase
American Journal of Clinical Pathology
|January 1, 1982
Summary
Antibodies against Coagulation Factor VIII can identify neoplastic endothelial cells. This study explored using Factor VIII to identify neoplastic megakaryocytes in leukemia.
Area of Science:
- Hematology
- Oncology
- Immunohistochemistry
Background:
- Coagulation Factor VIII (FVIII) is crucial for hemostasis.
- FVIII is produced by endothelial cells and megakaryocytes.
- Antibodies against FVIII are established markers for endothelial cells.
Observation:
- The utility of FVIII as a marker for neoplastic megakaryocytes was previously undescribed.
- This study investigated the expression of FVIII in megakaryocytic leukemia.
Findings:
- Immunoperoxidase staining for FVIII successfully identified megakaryocytes and their precursors.
- This demonstrates FVIII's potential as a marker for neoplastic megakaryocytes.
Implications:
- FVIII immunohistochemistry may aid in diagnosing and classifying megakaryocytic leukemia.
- This technique could improve the identification of malignant megakaryocytic cells.